To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. Our first job is to listen to and observe what our customers need, and meet those needs with quality products and services. While we are not currently experiencing delays due to this pandemic, we expect that we could see them as the situation evolves. If you experience any issues, please contact ATCC Customer Service at For Technical questions please contact Thank you for your understanding, patience and flexibility as ATCC does everything it can to help reduce the impact of the coronavirus pandemic to our valued customers.

HCM-BROD-0029-C71 (ATCC® PDM-22)

Organism: Homo sapiens, human  /  Tissue: brain  /  Disease: recurrent glioblastoma

Permits and Restrictions

View Permits

Organism Homo sapiens, human
Tissue brain
Product Format frozen 1.0 mL
Culture Properties aggregate/suspension
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease recurrent glioblastoma
Age See associated clinical data for patient profile information, if available.

Gender male
Ethnicity See associated clinical data for patient profile information, if available.

Applications Basic research, compound screening
Storage Conditions liquid nitrogen vapor phase
Clinical Data

ICD-10-CM code: C71, malignant neoplasm of cerebrum; Recurrent glioblastoma

See associated clinical data for patient profile information, if available.

Comments Next-generation cancer model from the Human Cancer Models Initiative (HCMI). Refer to the following websites for additional information on this model including protocols, clinical information, and bioinformatics data.

If use of this culture results in a scientific publication, it should be cited in that manuscript in the following manner: HCM-BROD-0029-C71 (ATCC® PDM-­22).

Additionally, please acknowledge the HCMI as follows: “We used models and data derived by the Human Cancer Models Initiative (HCMI); dbGaP accession number phs001486.”

Complete Growth Medium

NeuroCult NS-A Basal Medium (StemCell Technologies #05750) with NS-A Proliferation Supplement (StemCell Technologies #05754) + 20 ng/mL EGF (StemCell Technologies #78003.1) + 20 ng/mL bFGF (Peprotech #AF-100-15) + 2 µg/mL Heparin (StemCell Technologies #07980).

Prepare media according to the manufacturer’s instructions: Stem Cell Technologies Catalog #5751

Important: use Ultra Low Attachment (ULA) flasks/plates when culturing this model such as Corning #3814.

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2.5-5 X 105 cells/mL and maintain between below 1 X 106 cells/mL.

Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density). Large neurospheres should be mechanically dissociated to small fragments by repeated pipetting. Do not dissociate to single cells.
Cryopreservation Complete growth media containing 10% DMSO (ATCC 4-X).
Culture Conditions
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C
Cells per Vial ≥ 1 x 106 cells
Volume 1.0 mL
STR Profile
Amelogenin: X,Y
CSF1PO: 10,11
D13S317: 11
D16S539: 12,13
D5S818: 10,12
D7S820: 7,10
TH01: 9,9.3
vWA: 15,19
Sterility Tests Bacteria, yeast and fungi: No growth
Mycoplasma: No growth
Viral Testing Hepatitis B: None detected
Cytomegalovirus: None detected
Human immunodeficiency virus: None detected
Epstein-Barr virus: None detected
Human papillomavirus: None detected
Name of Depositor Broad Institute
Year of Origin 2018
Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation
  1. Animal-derived components in Organoids

    Date Updated: 3/26/2020

  2. Clinical and Sequence Data for Organoids
    HCMI model clinical and sequencing information is
    Date Updated: 3/26/2020
  3. GDC controlled access for Organoid data
    An eRA Commons account (
    Date Updated: 3/26/2020
  4. Data for Organoids

    Date Updated: 3/26/2020